Abstract
We establish the principal that the prediction, timing and magnitude of second and more distinct waves of infection can be based on the well - known physics and assumptions of classical diffusion theory. This model is fundamentally different from the commonly used SEIR and R0 fitting methods. Driven by data, we seek a working approximation for the observed orders of magnitude for the timing and rate of second and more waves. The dynamic results and characteristics are compared to the data and enable predictions of timescales and maximum expected rates where diffusive effects dominate.
The important point is this simple physical model allows understanding of the dominant processes, provides prediction estimates, and is based the solutions derived from existing, consistent and well-known physical principles. The medical system and health policy implications of such inexorable diffusive spread are that any NPI and other countermeasures deployed for and after the rapid first peak must recognize that large residual infection waves will then likely occur.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
There are no sources of financial support, and the work reported here is independent of any organization or entity, and for which the author has not received any contracts, fees, reimbursement, grants, or emoluments, including all monetary and any other considerations.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
None applicable
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data publicly available via world-in-data website
Nomenclature
- D
- Effective community diffusion coefficient
- d
- Elapsed time in days
- G
- Initial characteristic infection rate
- k
- Learning countermeasure characteristic rate
- L
- Characteristic transmission societal scale
- L*
- Diffusive scale ratio, (4Dd /L 2)½
- NPIN
- on-pharmaceutical intervention
- n
- Number of infections in any day
- R*
- Infection number ratio, R* = θ (d)/ θ (d0).
- t
- Time
- θ
- Non-dimensional number ratio (eq 5)
- Subscripts
- M1
- Maximum value at Peak 1
- M2
- Maximum or asymptotic value of second wave
- m
- Minimum achieved or attainable value
- 0
- Initial or beginning value
- 01
- Initial value for onset of Peak 1
- 02
- Initial value for onset of second wave
